Isolation of a novel cancer cachectic factor

Proceedings of the Nutrition Society

Volumn 56, Issue 2, 1997, Pages 777-783

  Tisdale, Michael J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ICOSAPENTAENOIC ACID; TUMOR PROTEIN;

ANIMAL; CACHEXIA; HUMAN; ISOLATION AND PURIFICATION; LIPID METABOLISM; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

ANIMALS; CACHEXIA; CYTOKINES; EICOSAPENTAENOIC ACID; HUMANS; LIPID METABOLISM; NEOPLASM PROTEINS; NEOPLASMS;

EID: 0031181719     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS19970078     Document Type: Conference Paper

References (46)

1. Bandyopadhyay, G. K., Imagawa, W., Wallace, D. R. & Nandi, S. (1988). Proliferative effects of insulin and epidermal growth factor on mouse mammary epithelial cells in primary culture. Enhancement by hydroxyeicosatetraenoic acids and synergism with prostaglandin E2. Journal of Biological Chemistry 263, 7567-7573.
2. Beck, S. A., Groundwater, P., Barton, C. & Tisdale, M. J. (1990a). Alterations in serum lipolytic activity of cancer patients with response to therapy. British Journal of Cancer 62, 822-825.
3. Beck, S. A., Mulligan, H. D. & Tisdale, M. J. (1990b). Lipolytic factors associated with murine and human cancer cachexia. Journal of the National Cancer Institute 82, 1922-1926.
4. Beck, S. A. & Tisdale, M. J. (1987). Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Research 47, 5919-5923.
5. Beck, S. A. & Tisdale, M. J. (1991). Lipid mobilising factors specifically associated with cancer cachexia. British Journal of Cancer 63, 846-850.
6. Belizario, J. E., Katz, M. & Raw, C. I. (1991). Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss. British Journal of Cancer 63, 705-710.
7. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R. & Cerami, A. (1985). Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552-554.
8. Bibby, M. C., Double, J. A., Ali, S. A., Fearon, K. C. H., Brennan, R. A. & Tisdale, M. J. (1987). Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. Journal of the National Cancer Institute 78, 539-546.
9. Cohn, S. H., Gartenhaus, W. & Sawitsky, A. (1981). Compartmental body composition of cancer patients with measurement of total body nitrogen, potassium and water. Metabolism 30, 222-229.
10. Costa, G. (1977). Cachexia, the metabolic component of neoplastic disease. Cancer Research 37, 2327-2335.
11. Costa, G. & Holland, J. F. (1966). Effects of Krebs-2 carcinoma on the lipid metabolism of male Swiss mice. Cancer Research 22, 1081-1083.
12. Costa, G., Lane, W. W., Vincint, R. G., Siebold, J. A., Aragon, M. & Bewley, P. T. (1980). Weight loss and cachexia in lung cancer. Nutrition and Cancer 2, 98-103.
13. Demetrakopoulos, G. E. V. & Brennan, M. F. (1982). Tumoricidal potential of nutritional manipulation. Cancer Research 42, Suppl., 756s-761s.
14. De Wys, W. (1985). Management of cancer cachexia. Seminars in Oncology 12, 452-460.
15. Evans, W. K., Makuch, R., Clamon, G. H., Feld, K., Weiner, R. S., Moran, E., Blum, R., Shepherd, F. E., Jeejeebhoy, K. N. & De Wys, W. D. (1985). Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer. Cancer Research 45, 3347-3353.
16. Fearon, K. C. H., McMillan, D. C., Preston, T., Winstanley, P., Cruickshank, A. M. & Shenkin, A. (1991). Elevated circulating interleukin-6 is associated with an acute phase response but reduced fixed hepatic protein synthesis in patients with cancer. Annals of Surgery 213, 26-31.
17. Flores, E. A., Bistrian, B. R., Pomposelli, J. J., Dinarello, C. A., Blackburn, G. L. & Istfan, N. (1989). Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. Journal of Clinical Investigation 83, 1614-1622.
18. Garcia-Martinez, C., Lopez-Soriano, F. J. & Argiles, J. M. (1994). Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Letters 76, 1-4.
19. Glasgow, W. C. & Eling, T. E. (1990). Epidermal growth factor stimulates linoleic acid metabolism in BALB/c 3T3 fibroblasts. Molecular Pharmacology 38, 503-510.
20. 2 production in rat skeletal muscle fever is signaled by a macrophage product distinct from interleukin-1 or other known monokines. Journal of Clinical Investigation 81, 1378-1383.
21. Grosvenor, M., Bulcavage, L. & Chlebowski, R. T. (1989). Symptoms potentially influencing weight loss in a cancer population. Cancer 63, 330-335.
22. Groundwater, P., Beck, S. A., Barton, C., Adamson, C., Ferrier, I. N. & Tisdale, M. J. (1990). Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. British Journal of Cancer 62, 816-821.
23. Kitada, S., Hays, E. F. & Mead, J. F. (1980). A lipid mobilizing factor in serum of tumour-bearing mice. Lipids 15, 168-174.
24. Loprinzi, C. L., Michalak, J. C. & Schaid, D. J. (1993a). Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Journal of Clinical Oncology 11, 762-768.
25. Loprinzi, C. L., Schaid, D. J., Dose, A. M., Burnham, N. L. & Jensen, M. D. (1993b). Body composition changes in patients who gain weight while receiving megestrol acetate. Journal of Clinical Oncology 11, 152-157.
26. McDevitt, T. M., Todorov, P. T., Beck, S. A., Khan, S. H. & Tisdale, M. J. (1995). Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans. Cancer Research 55, 1458-1463.
27. McMillan, D. C., Simpson, J. M., Preston, T., Watson, W., Fearon, K. C. H., Shenkin, A., Burns, H. J. G. & Mcardle, C. S. (1994). Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients. Clinical Nutrition 13, 69-75.
28. Mahony, S. M., Beck, S. A. & Tisdale, M. J. (1988). Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour. British Journal of Cancer 57, 385-389.
29. Masuno, H., Yamaskai, N. & Okuda, H. (1981). Purification and characterization of a lipolytic factor (toxohormone-L) from cell free fluid of ascites Sarcoma 180. Cancer Research 41, 284-288.
30. Masuno, H., Yoshimura, H., Ogawa, N. & Okuda, H. (1984). Isolation of a lipolytic factor (toxohormone-L) from ascites fluid of patients with hepatoma and its effect on feeding behaviour. European Journal of Cancer and Clinical Oncology 20, 1177-1185.
31. Oversen, L., Allingstrup, L., Hannibal, J., Mortensen, E. L. & Hansen, O. P. (1993). Effect of dietary counseling on food intake, body weight, response rate, survival and quality of life in cancer patients undergoing chemotherapy. A prospective, randomized study. Journal of Clinical Oncology 11, 2043-2048.
32. Pfizer, L. I. & Regan, J. D. (1972). Basis for the serine requirement in leukemic and normal human leukocytes. Reduced levels of the enzymes in the phosphorylated pathway. Journal of the National Cancer Institute 48, 1897-1900.
33. Sauer, L. A. & Dauchy, R. T. (1987a). Blood nutrient concentrations and tumor growth in vivo in rats: relationships during the onset of an acute fast. Cancer Research 47, 1065-1068.
34. Sauer, L. A. & Dauchy, R. T. (1987b). Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes. Cancer Research 47, 1756-1761.
35. Scagliotti, G. V., Gatti, E., Ferrari, G., Multi, L. & Pozzi, E. (1995). TNF-α determination in serum and pleural effusion in patients with lung cancer. International Journal of Oncology 6, 147-151.
36. Smith, K. L. & Tisdale, M. J. (1993). Mechanism of muscle protein degradation in cancer cachexia. British Journal of Cancer 68, 314-318.
37. Socher, S. H., Martinez, D., Craig, J. B., Kuhn, J. G. & Oliff, A. (1988). Tumour necrosis factor not detectable in patients with clinical cancer cachexia. Journal of the National Cancer Institute 80, 595-598.
38. Tang, D. G., Chen, Y. O. & Honn, K. V. (1996). Arachidonate lipoxygenases as esssential regulators of cell survival and apoptosis. Proceedings of the National Academy of Sciences USA 93, 5241-5246.
39. Taylor, D. D., Gercel-Taylor, C., Jenio, L. G. & Devereux, D. (1992). Identification of a human tumor-derived lipolysis-promoting factor. Cancer Research 52, 829-834.
40. Thompson, M. P., Cooper, S. T., Parry, B. R. & Tuckey, J. A. (1993). Increased expression of the mRNA for the hormone-sensitive lipase in adipose tissue of cancer patients. Biochimica et Biophysica Acta 1180, 236-242.
41. Tisdale, M. J. (1980). Effect of methionine replacement by homocysteine on the growth of cells. Cell Biology International Report 4, 563-567.
42. Tisdale, M. J. & Beck, S. A. (1991). Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid. Biochemical Pharmacology 41, 103-107.
43. Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K. & Tisdale, M. (1996a). Characterization of a cancer cachectic factor. Nature 379, 739-742.
44. Todorov, P. T., McDevitt, T. M., Cariuk, P., Coles, B., Deacon, M. & Tisdale, M. J. (1996b). Induction of muscle protein degradation and weight loss by a tumour product. Cancer Research 56, 1256-1261.
45. Uren, J. R. & Lazarus, H. (1979). L-Cyst(e)ine requirements of malignant cells and progress towards depletion therapy. Cancer Treatment Reports 63, 1073-1079.
46. Wigmore, S. J., Ross, J. A., Falconer, J. S., Plester, C. E., Tisdale, M. J., Carter, D. C. & Fearon, K. C. H. (1996). The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12, S27-S30.